Breaking news coverage from cryptocurrency world about key figures, exchanges, startups, investment, applications, regulation and more.
Gavin Newsom, California Governor, is ‘not worried’ about CEO Elon Musk shifting Tesla out of the state as CEO faces legal battles over tweets. TSLA stock is up around 1% today.
Leading cryptocurrency exchange platform Changelly has added UTK, the native token of the Utrust digital payment system.
After closing yesterday with a 1% loss, JNJ stock was 0.34% down further in the pre-market today but is 0.72% up now. Johnson & Johnson announces that it will stop selling its talc baby powder in the U.S. and also in Canada.
Ripple’s XRP has got approval for being used in cross-border money transfers from the U.S.Consumer Financial Protection Bureau. XRP price is rising now.
Spotify has announced its partnership with popular podcast personality Joe Rogan. SPOT stock jumped 8% yesterday and is 5% up today.
Currently, Bitcoin isn’t “hard money.” Its supply is not fixed, and will not be for a very long time. The famous 21 million limit won’t be reached for over a century if it is ever reached at all. eToro analyst Simon Peters believes that Bitcoin price has all chances to reach the level of $120,000 within 18 months after the halving.
FAANG stocks have been defying the coronavirus market disruption as they continue to scale higher every day. The NYSE FANG+ Index is up around 21% since the beginning of the year.
Bitcoin (BTC) price are expected to rise. This could happen because of several reasons which are currently at play. Bitcoin price could hit $10,00 and take off. However, it is said that less than 1% of the stimulus money being sent to U.S. citizens in two waves will be enough to buy the entire supply of new BTC in 2020.
Facebook (FB) stock price is rising as Mark Zuckerberg announced the introduction of Facebook Shops which is a shopping feature available for free to users of Facebook, Instagram and Whatsapp.
As Stat News has reported, it is too early to assess the COVID-19 vaccine offered by Moderna. Most of what Moderna disclosed “were words, not data”, while the critical information has been withheld. MRNA stock is down.